$1.43 -0.08 (%) Apricus Biosciences Inc - NASDAQ

Oct. 1, 2014 | 04:00 PM

Partner Headlines

  1. Apricus Biosciences Announces National Phase Approval for Vitaros in Spain

    Benzinga | Apr. 24, 2014 | 08:08AM EST
  2. Apricus Biosciences Announces National Phase Approval for Vitaros in Luxembourg

    Benzinga | Apr. 3, 2014 | 08:03AM EST
  3. Earnings Scheduled For March 17, 2014

    Benzinga | Mar. 17, 2014 | 04:59AM EST
  4. Apricus Expands Exclusive License Agreement With Sandoz Affiliate, Apricus to Receive Up to $63M in Milestone Payments

    Benzinga | Dec. 16, 2013 | 07:09AM EST
  5. Apricus Elects Kleanthis G. Xanthopoulos as New Chairman

    Benzinga | Dec. 11, 2013 | 07:08AM EST
  6. Apricus Announces Laboratoires Majorelle to Market Vitaros in France, Monaco and Certain African Countries

    Benzinga | Nov. 13, 2013 | 06:25AM EST
  7. Apricus Reports National Phase Approval of ED Cream in Germany

    Benzinga | Oct. 7, 2013 | 07:02AM EST
  8. UPDATE: Cantor Fitzgerald Initiates Coverage on Apricus Biosciences on Cautious Stance

    Benzinga | Aug. 23, 2013 | 11:03AM EST
  9. Benzinga's Top Initiations

    Benzinga | Aug. 23, 2013 | 09:03AM EST
  10. Apricus Biosciences Reports Vitaros National Phase Approvals in UK, Sweden

    Benzinga | Aug. 12, 2013 | 07:07AM EST
  11. Apricus Biosciences Reports on Corporate Goals for 2013

    Benzinga | Jan. 3, 2013 | 00:06AM EST
  12. Apricus Biosciences Receives $2.5M Payment From Abbott Laboratories

    Benzinga | Oct. 18, 2012 | 00:16AM EST
  13. Benzinga's Top Pre-Market Gainers

    Benzinga | Oct. 1, 2012 | 02:12AM EST
  14. Apricus Biosciences Announces Intent to File NDS for MycoVa in Canada

    Benzinga | Oct. 1, 2012 | 00:22AM EST
  15. A Peek Into The Market Before The Trading Starts

    Benzinga | Sep. 13, 2012 | 01:17AM EST
  16. Apricus Biosciences Subsidiary NexMed and Takeda Pharmaceuticals Sign Agreement to Market Vitaros in UK

    Benzinga | Sep. 13, 2012 | 00:03AM EST
  17. Apricus Biosciences Issues Statement Regarding Registration of Shares Related to Finesco/Scomedica and PediatRx Transactions

    Benzinga | Jul. 17, 2012 | 06:11AM EST
  18. Select Comfort, Mitcham Industries Among Stocks Down on Above-average Volume Wednesday

    FoxBusiness | Jun. 6, 2012 | 06:33AM EST
  19. Apricus Bioscience, Quepasa Corporation Among Stocks setting 52-Week Lows Wednesday

    FoxBusiness | Jun. 6, 2012 | 06:32AM EST
  20. Apricus Biosciences Strengthens Vitaros and Nexact Patent Estate With Two New Patent Allowances

    Benzinga | May. 25, 2012 | 07:25AM EST
  21. Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) for the Treatment of Female Sexual Arousal Disorder

    Benzinga | May. 21, 2012 | 03:35AM EST
  22. Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) for the Treatment of Onychomycosis

    Benzinga | May. 11, 2012 | 03:58AM EST
  23. Apricus Bioscience's Wholly-Owned Subsidiary NexMed Signs Exclusive German Collaboration for Vitaros for Erectile Dysfunction

    Benzinga | Feb. 15, 2012 | 05:37AM EST
  24. Apricus Biosciences and Elis Pharma Sign License Agreement for MycoVa in the Middle East and the Gulf

    Benzinga | Jan. 10, 2012 | 02:51AM EST
  25. Apricus Biosciences and Abbott Sign Exclusive Agreement to Market Vitaros in Canada

    Benzinga | Jan. 9, 2012 | 05:29AM EST
  26. Apricus Biosciences and Stellar Pharmaceuticals Announce Exclusive License Agreement in Canada for the Commercialization of MycoVa for Onychomycosis

    Benzinga | Jan. 3, 2012 | 08:26AM EST
  27. Apricus Biosciences Enters into Exclusive License Agreement with Stellar Pharmaceuticals to Market MycoVa in Canada

    Benzinga | Dec. 30, 2011 | 10:12AM EST
  28. Apricus Biosciences Announces Allowance of Additional NexACT Patent in Japan

    Benzinga | Dec. 8, 2011 | 03:01AM EST
Trading Center